NCT03437018|CompletedDMC
MONITORING OF MODERATE DIABETIC RETINOPATHY BY TELE-EXPERTISE
TELERETINODIAB
COMPARISON OF MONITORING OF MODERATE DIABETIC RETINOPATHY BY TELE-EXPERTISE AND CONVENTIONAL OPHTHALMOLOGICAL CONSULTATION
Loading search results
TELERETINODIAB
COMPARISON OF MONITORING OF MODERATE DIABETIC RETINOPATHY BY TELE-EXPERTISE AND CONVENTIONAL OPHTHALMOLOGICAL CONSULTATION
Sponsor study identifier
observational
97
1 country
1
Study Start
October 10, 2019
Actual (reported)Primary Completion
June 16, 2022
Actual (reported)Study Completion
June 16, 2022
Actual (reported)The aim of this study is to evaluate the monitoring of moderate diabetic retinopathy by tele-expertise
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 16, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 26, 2018
Actual (reported)February 19, 2018
Actual (reported)October 10, 2019
Actual (reported)June 16, 2022
Actual (reported)June 16, 2022
Actual (reported)classification of diabetic retinopathy (DR)
DR is classified in 3 stages : moderate non proliferative DR, severe non proliferative DR, and proliferative DR
1 month
classification of macular edema
1 month
follow-up strategy
1 month
medical time necessary for examination and analyse
1 month
Consultation by an orthoptist to measure visual acuity, eye tone by pulsed air tonometer, and retinography images after pupillary dilatation (9 photographs: one of the posterior pole and 8 of the peripheral retina) and optical coherence tomography (OCT). The results are immediately evaluated on site by an ophthalmologist. The results are sent through a secure online medical application to a diabetic retinopathy specialist ophthalmologist for evaluation.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
patient with complicated diabetes mellitus with moderate retinopathy requiring periodic follow-up by an ophthalmologist
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, 91106, France
Schulze-Dobold C, Erginay A, Robert N, Chabouis A, Massin P. Ophdiat((R)): five-year experience of a telemedical screening programme for diabetic retinopathy in Paris and the surrounding area. Diabetes Metab. 2012 Nov;38(5):450-7. doi: 10.1016/j.diabet.2012.05.003. Epub 2012 Jul 4.
Chabouis A, Berdugo M, Meas T, Erginay A, Laloi-Michelin M, Jouis V, Guillausseau PJ, M'bemba J, Chaine G, Slama G, Cohen R, Reach G, Marre M, Chanson P, Vicaut E, Massin P. Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres. Diabetes Metab. 2009 Jun;35(3):228-32. doi: 10.1016/j.diabet.2008.12.001. Epub 2009 Apr 5.
Alfred Penfornis
Centre Hospitalier Sud Francilien
97 participants (actual enrollment reported by the registry).
First Submitted
January 26, 2018
First Posted
February 19, 2018
Study Start
October 10, 2019
Actual (reported)A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy
Contact the study team to confirm eligibility.
Erginay A, Chabouis A, Viens-Bitker C, Robert N, Lecleire-Collet A, Massin P. OPHDIAT: quality-assurance programme plan and performance of the network. Diabetes Metab. 2008 Jun;34(3):235-42. doi: 10.1016/j.diabet.2008.01.004.
Primary Completion
June 16, 2022
Actual (reported)Study Completion
June 16, 2022
Actual (reported)Last Updated
May 22, 2026
Record last verified: 2026-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: